CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
Cash flows from operating activities:
Net loss	$ (3,157,852)	$ (6,824,004)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	3,557	2,469
Amortization	105,882	112,732
Provision for bad debt expense	140,152	(51,769)
Provision for inventory losses	110,000	0
Change in estimated fair value of derivative	(3,026,433)	(749,943)
Fair value of common stock issued for services	18,000	470,062
Stock based compensation	229,858	453,491
Change in operating assets and liabilities:
Accounts receivable	1,258,991	(104,970)
Inventory	707,364	(903,897)
Prepaid expenses and other current assets	(160,523)	386,768
Accounts payable and accrued expenses	(623,123)	(142,177)
Net cash used in operating activities	(4,394,127)	(7,351,238)
Cash flows from investing activities:
Restricted cash	(158)	(76,110)
Purchase of property and equipment	(11,775)	0
Net cash used in investing activities	(11,933)	(76,110)
Cash flow from financing activities:
Proceeds from warrants exercised for cash	45,000	0
Proceeds from issuance of Series C Preferred Stock	6,000,000	9,000,048
Borrowings on debt	94,998	1,035,792
Repayments on debt	(703,778)	(3,184,786)
Net cash provided by financing activities	5,436,220	6,851,054
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	1,030,160	(576,294)
CASH AND CASH EQUIVALENTS - beginning of period	376,840	668,326
CASH AND CASH EQUIVALENTS - end of period	1,407,000	92,032
SUPPLEMENTAL DISCLOSURES
Interest paid in cash	41,758	137,556
Non-cash transactions:
Conversion of preferred stock to common stock	1,473	54,034
Dividend paid in common stock	198,449	203,397
Dividends declared	198,929	68,636
Conversion of notes payable and accrued interest to Series C preferred stock	500,000	1,214,206
Warrants issued in connection with Series C Preferred Offering	3,159,721	2,858,742
Issuance of restricted stock	$ 2,620